PATIENTS OF HIGH AGE WITH ADVANCED TRANSITIONAL CELL-CARCINOMA TREATED BY M-VAC CHEMOTHERAPY

被引：2
|
作者：
SAGASTER, P
FLAMM, J
ESSL, R
TEICH, G
机构：
来源：
AKTUELLE UROLOGIE | 1987年 / 18卷 / 06期
关键词：
D O I：
10.1055/s-2008-1061473
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：325 / 329
页数：5
相关论文
共 50 条
  • [31] 2ND-LINE M-VAC THERAPY IN PATIENTS PREVIOUSLY TREATED WITH THE M-VAC REGIMEN FOR METASTATIC UROTHELIAL CANCER
    KATTAN, J
    CULINE, S
    THEODORE, C
    DROZ, JP
    ANNALS OF ONCOLOGY, 1993, 4 (09) : 793 - 794
  • [32] PRIMARY TRANSITIONAL CELL-CARCINOMA OF PROSTATE - CASE WITH LYMPH-NODE METASTASIS ERADICATED BY NEOADJUVANT METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN (M-VAC) THERAPY
    TAKASHI, M
    SAKATA, T
    NAGAI, T
    KATO, T
    SAHASHI, M
    KOSHIKAWA, T
    MIYAKE, K
    UROLOGY, 1990, 36 (01) : 96 - 98
  • [33] Post-chemotherapy surgery after M-VAC in patients (PTS) with metastatic transitional cell carcinoma (TCC) can result in long-term survival.
    Dodd, PM
    McCaffrey, JA
    Herr, H
    Vlamis, V
    Mazumdar, M
    Higgins, G
    Scher, HI
    Bajorin, DF
    JOURNAL OF UROLOGY, 1998, 159 (05): : 166 - 166
  • [34] TRANSITIONAL CELL-CARCINOMA OF THE OVARY - A MATCHED CONTROL STUDY OF ADVANCED-STAGE PATIENTS TREATED WITH CISPLATIN-BASED CHEMOTHERAPY
    GERSHENSON, DM
    SILVA, EG
    MITCHELL, MF
    ATKINSON, EN
    WHARTON, JT
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 168 (04) : 1178 - 1187
  • [35] Anatomic site of primary transitional cell carcinoma (TCC) does not affect probability of response to M-Vac or survival.
    McCaffrey, JA
    Dodd, PM
    Herr, H
    Vlamis, V
    Mazumdar, M
    Higgins, G
    Scher, HI
    Bajorin, DF
    JOURNAL OF UROLOGY, 1998, 159 (05): : 166 - 166
  • [36] ADJUVANT CHEMOTHERAPY FOR UROEPITHELIAL TRANSITIONAL CELL-CARCINOMA
    KURIYAMA, M
    TAKEUCHI, T
    FUJIHIRO, S
    FUJIMOTO, Y
    SHINODA, I
    TAKAHASHI, Y
    YAMADA, S
    NISHIURA, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 : S29 - S33
  • [37] INVITRO CHEMOTHERAPY TESTING OF TRANSITIONAL CELL-CARCINOMA
    SHRIVASTAV, S
    PAULSON, DF
    INVESTIGATIVE UROLOGY, 1980, 17 (05): : 395 - 400
  • [38] TRANSITIONAL CELL-CARCINOMA IN PATIENTS UNDER 40 YEARS OF AGE
    STOKES, MA
    KELLY, DG
    BRITISH JOURNAL OF UROLOGY, 1987, 59 (06): : 536 - 539
  • [39] ROLE OF M-VAC COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED UROTHELIAL BLADDER-CANCER
    STOCKLE, M
    MEYENBURG, W
    WELLEK, S
    VOGES, G
    GERTENBACH, U
    THUROFF, JW
    HUBER, C
    HOHENFELLNER, R
    ANNALES D UROLOGIE, 1993, 27 (01) : 51 - 57
  • [40] PERIOPERATIVE METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN (M-VAC) FOR POOR RISK TRANSITIONAL CELL-CARCINOMA OF THE BLADDER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PILOT-STUDY
    DREICER, R
    MESSING, EM
    LOEHRER, PJ
    TRUMP, DL
    JOURNAL OF UROLOGY, 1990, 144 (05): : 1123 - 1127
12345